Quadrature Capital LTD Bausch Health Companies Inc. Transaction History
Quadrature Capital LTD
- $4.51 Trillion
- Q1 2025
A detailed history of Quadrature Capital LTD transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Quadrature Capital LTD holds 71,200 shares of BHC stock, worth $330,368. This represents 0.01% of its overall portfolio holdings.
Number of Shares
71,200Holding current value
$330,368% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding BHC
# of Institutions
271Shares Held
242MCall Options Held
3.66MPut Options Held
11.3M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$161 Million3.02% of portfolio
-
Goldentree Asset Management LP New York, NY30.3MShares$140 Million17.26% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$123 Million9.81% of portfolio
-
Nomura Holdings Inc Tokyo, M023.4MShares$109 Million0.32% of portfolio
-
Healthcare Of Ontario Pension Plan Trust Fund Toronto, A613MShares$60.3 Million0.19% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $1.68B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...